Cathelicidin deficiency predisposes to eczema herpeticum
- 30 April 2006
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 117 (4), 836-841
- https://doi.org/10.1016/j.jaci.2005.12.1345
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Interleukin-10 Downregulates Anti-Microbial Peptide Expression in Atopic DermatitisJournal of Investigative Dermatology, 2005
- Human Cathelicidin (LL-37), a Multifunctional Peptide, is Expressed by Ocular Surface Epithelia and has Potent Antibacterial and Antiviral ActivityCurrent Eye Research, 2005
- New insights into atopic dermatitisJCI Insight, 2004
- Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response GenesThe Journal of Immunology, 2003
- Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 casesJournal of the American Academy of Dermatology, 2003
- Rapid Detection of Herpes Simplex Virus and Varicella-Zoster Virus Infections by Real-Time PCRJournal of Clinical Microbiology, 2003
- Atopic dermatitisThe Lancet, 2003
- The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory DisordersJournal of Biological Chemistry, 1997
- Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.JCI Insight, 1994
- Eczema herpeticum: a potentially fatal disease.BMJ, 1987